---
document_datetime: 2023-09-21 22:16:22
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/sitagliptinmetformin-hydrochloride-sun-epar-all-authorised-presentation_en.pdf
document_name: sitagliptinmetformin-hydrochloride-sun-epar-all-authorised-presentation_en.pdf
version: success
processing_time: 1.052356
conversion_datetime: 2025-12-15 19:30:36.47598
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Pack size

| EU/1/23/1720/001   | Sitagliptin/Metformin hydrochloride SUN   | 50 mg / 850 mg   | Film-coated tablet   | Oral use   | bottle (HDPE)   | 28 tablets   |
|--------------------|-------------------------------------------|------------------|----------------------|------------|-----------------|--------------|
| EU/1/23/1720/002   | Sitagliptin/Metformin hydrochloride SUN   | 50 mg / 850 mg   | Film-coated tablet   | Oral use   | bottle (HDPE)   | 56 tablets   |
| EU/1/23/1720/003   | Sitagliptin/Metformin hydrochloride SUN   | 50 mg / 850 mg   | Film-coated tablet   | Oral use   | bottle (HDPE)   | 200 tablets  |
| EU/1/23/1720/004   | Sitagliptin/Metformin hydrochloride SUN   | 50 mg / 1000 mg  | Film-coated tablet   | Oral use   | bottle (HDPE)   | 28 tablets   |
| EU/1/23/1720/005   | Sitagliptin/Metformin hydrochloride SUN   | 50 mg / 1000 mg  | Film-coated tablet   | Oral use   | bottle (HDPE)   | 56 tablets   |
| EU/1/23/1720/006   | Sitagliptin/Metformin hydrochloride SUN   | 50 mg / 1000 mg  | Film-coated tablet   | Oral use   | bottle (HDPE)   | 200 tablets  |